Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Medica and Qure.ai partner to use AI

23 Mar 2020 07:00

RNS Number : 1143H
Medica Group PLC
23 March 2020
 

23 March 2020

 

 

Medica and Qure.ai partner to use artificial intelligence to improve efficiency of workflow and clinical decision support

 

Medica Group Plc (LSE: MGP, "Medica" or the "Company"), the UK market leader in teleradiology services, and Qure.ai, a global leader in artificial intelligence (AI) solutions for radiology, announce a strategic partnership to develop AI tools for prioritisation and improved efficiency of radiology scan workload.

 

Under the terms of the agreement, Medica will partner with Qure.ai in two important areas:

· The first is to launch a decision support tool for CT (computed tomography) head scan examinations. This tool will flag potential urgent examinations allowing prioritisation of reporting based on clinical priority as opposed to chronological allocation. The tool will also highlight potentially critical findings to reporters, which can be integrated into their diagnoses. The tool will be trialed and implemented to augment Medica's urgent, out-of-hours NightHawk service.

· The second area is to co-develop a bespoke AI-based automated workflow improvement tool that aims to improve the efficiency of study allocation from NHS clients to Medica's network of over 435 reporters.

 

Stuart Quin, Chief Executive Officer of Medica commented:

"Medica has been actively following the development of decision support tools using artificial intelligence to better understand the benefit to our clients. As we indicated in September 2019, our focus has been on areas that can have an immediate improvement to workflow and can support clinical decision making. As a leader in artificial intelligence solutions for radiology with an impressive track record of successful deployment in teleradiology workflows, backed up by peer-reviewed studies, Qure.ai is an ideal partner."

 

Prashant Warier, Chief Executive Officer of Qure.ai commented:

"We are excited to partner with Medica, the UK's leading provider of teleradiology reporting, and we look forward to working with their team to realise the benefits of artificial intelligence in this important market. The tools being developed for Medica will improve efficiencies and support their strong network of highly skilled radiologists and radiographers."

 

For further information, please contact:

 

Medica Group

Stuart Quin, Chief Executive Officer

Kevin Terrins, Business Development Director

 

+44 (0)33 33 111 222

Qure.ai

Prashant Warier, Chief Executive Officer

Rohit Ghosh, Business Development Director

 

 

 

rohit.ghosh@qure.ai

FTI Consulting

Victoria Foster Mitchell

Robert Winder

+44 (0)20 3727 1000

 

 

 

About Medica Group PLC

Medica is the UK market leader in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional reporting on MRI and CT scans, and routine plain film reporting on x-ray images.

Medica has developed a bespoke, secure IT platform that provides market-leading linkage between a hospital's radiology information system (RIS) and consultant radiologists who contract with Medica. Direct RIS access ensures that the full wider patient information is available and reviewed with every report.

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.3 million examinations annually across its customer base of more than 100 NHS Trusts and various private hospital groups and diagnostic imaging companies.

 

For more information please visit www.medicagroup.co.uk.

 

About Qure.ai

Headquartered in Mumbai, India, with U.S. operations in San Francisco and New York, Qure.ai is a breakthrough Artificial Intelligence (AI) solution developer that is disrupting the radiology 'status quo' by enhancing imaging accuracy and improving health outcomes with the assistance of machine-supported tools. Qure.ai taps deep learning technology to provide automated interpretation of radiology exams like X-rays, CTs and MRI scans for time and resource-strapped medical imaging professionals-enabling faster diagnosis and speed to treatment. Qure.ai is helping make healthcare more accessible and affordable to patients worldwide.

 

For more information, please visit www.qure.ai.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRKKBBQQBKDCNB
Date   Source Headline
1st Aug 20225:33 pmRNSHolding(s) in Company
1st Aug 20222:58 pmRNSIssue of Equity and Total Voting Rights
1st Aug 202212:13 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSTrading update and full year outlook
25th Jul 20222:30 pmRNSHolding(s) in Company
30th Jun 20227:00 amRNSBlock Listing Application
28th Jun 202212:46 pmRNSHolding(s) in Company
27th Jun 20221:58 pmRNSResult of AGM
27th Jun 20227:00 amRNSAGM Statement
27th May 20225:22 pmRNSNotice of AGM
19th May 20227:00 amRNSHolding(s) in Company
12th Apr 202211:29 amRNSPublication of Annual Report
4th Apr 20227:00 amRNSResults for the year ended 31 December 2021
9th Mar 20224:40 pmRNSSecond Price Monitoring Extn
9th Mar 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 20224:35 pmRNSPrice Monitoring Extension
16th Feb 202211:22 amRNSHolding(s) in Company
4th Feb 20223:05 pmRNSNotification of Major Holdings
28th Jan 20222:02 pmRNSNotification of Major Holdings
27th Jan 20221:19 pmRNSNotification of Major Shareholdings
26th Jan 20227:00 amRNSTrading and Business Update
24th Jan 20228:00 amRNSHolding(s) in Company
7th Jan 20227:00 amRNSAppointment of Numis as Joint Broker
5th Jan 20223:21 pmRNSBlock listing Interim Review
30th Dec 20213:48 pmRNSIssue of Equity
20th Dec 20214:36 pmRNSPrice Monitoring Extension
20th Dec 20218:00 amRNSHolding(s) in Company
25th Nov 20218:00 amRNSHolding(s) in Company
2nd Nov 202110:01 amRNSDirector/PDMR Shareholding
29th Oct 20219:18 amRNSTotal Voting Rights
8th Oct 20217:00 amRNSIssue of Equity
29th Sep 20217:00 amRNSRecord Date for Dividend – Correction
27th Sep 20217:00 amRNSInterim results for the six months to 30 June 2021
17th Sep 20211:47 pmRNSHolding(s) in Company
7th Sep 20217:00 amRNSCapital Markets Day
26th Aug 202110:17 amRNSHolding(s) in Company
17th Aug 202111:20 amRNSHolding(s) in Company
30th Jul 20217:00 amRNSIssue of Equity and Total Voting Rights
22nd Jul 20217:00 amRNSTrading and business update
8th Jul 20219:28 amRNSHolding(s) in Company
5th Jul 202110:49 amRNSBlock Listing Application
22nd Jun 20211:45 pmRNSDirector/PDMR Shareholding
21st Jun 20217:00 amRNSDirector/PDMR Shareholding
16th Jun 20211:00 pmRNSResult of AGM
16th Jun 20217:00 amRNSAGM Statement
15th Jun 20217:40 amRNSDirector Declaration
15th Jun 20217:00 amRNSMedica appoints Barbara Moorhouse as NED
11th Jun 20214:34 pmRNSDirector/PDMR Shareholding
9th Jun 20219:05 amRNSHolding(s) in Company
4th Jun 20211:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.